+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cancer Biopsy Market by Product (Instruments, Kits & Consumables, Services), Type (Liquid Biopsies, Tissue Biopsies), Indication - Forecast 2024-2030- Product Image
Global Cancer Biopsy Market by Product (Instruments, Kits & Consumables, Services), Type (Liquid Biopsies, Tissue Biopsies), Indication - Forecast 2024-2030- Product Image
Sale

Global Cancer Biopsy Market by Product (Instruments, Kits & Consumables, Services), Type (Liquid Biopsies, Tissue Biopsies), Indication - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5454883
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cancer Biopsy Market size was estimated at USD 29.84 billion in 2023, USD 33.48 billion in 2024, and is expected to grow at a CAGR of 12.28% to reach USD 67.14 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cancer Biopsy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cancer Biopsy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cancer Biopsy Market, highlighting leading vendors and their innovative profiles. These include Agena Bioscience, Inc., Agilent Technologies Inc., ANGLE PLC, Becton, Dickinson and Company, BIOCEPT, Inc., Danaher Corporation, Epigenomics AG, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Freenome Holdings, Inc., GRAIL, Inc., Guardant Health, HelioHealth, Hologic, Inc., Illumina, Inc., Laboratory Corporation of America Holdings, Lucence Health Inc., MDx Health, Myriad Genetics, Inc., Natera, Inc., OncoCyte Corp, Personalis Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., and Trovagene, Inc.

Market Segmentation & Coverage

This research report categorizes the Cancer Biopsy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
    • Kits & Consumables
    • Services
  • Type
    • Liquid Biopsies
    • Tissue Biopsies
      • Needle Biopsies
        • Core Needle Biopsy
        • Fine Needle Aspiration
      • Surgical Biopsies
  • Indication
    • Blood Cancers
    • Breast Cancer
    • Cervical Cancers
    • Colorectal Cancer
    • Kidney Cancers
    • Liver Cancers
    • Lung Cancers
    • Ovarian Cancers
    • Pancreatic Cancers
    • Prostate Cancers
    • Skin Cancers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Cancer Biopsy Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cancer Biopsy Market?
  3. What are the technology trends and regulatory frameworks in the Cancer Biopsy Market?
  4. What is the market share of the leading vendors in the Cancer Biopsy Market?
  5. Which modes and strategic moves are suitable for entering the Cancer Biopsy Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cancer Biopsy Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing preference for non-invasive procedures
5.1.1.2. Emerging significance of cancer biopsies and tissue sectioning
5.1.1.3. Growing adoption of liquid cancer biopsies
5.1.2. Restraints
5.1.2.1. Low sensitivity and specificity of cancer biopsies
5.1.3. Opportunities
5.1.3.1. Technological advancements in cancer biopsy devices
5.1.3.2. Increasing R&D activities for novel cancer treatments
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements and unclear reimbursement scenarios
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cancer Biopsy Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Kits & Consumables
6.4. Services
7. Cancer Biopsy Market, by Type
7.1. Introduction
7.2. Liquid Biopsies
7.3. Tissue Biopsies
7.4.1. Needle Biopsies
7.4.2.1. Core Needle Biopsy
7.4.2.2. Fine Needle Aspiration
7.4.2. Surgical Biopsies
8. Cancer Biopsy Market, by Indication
8.1. Introduction
8.2. Blood Cancers
8.3. Breast Cancer
8.4. Cervical Cancers
8.5. Colorectal Cancer
8.6. Kidney Cancers
8.7. Liver Cancers
8.8. Lung Cancers
8.9. Ovarian Cancers
8.10. Pancreatic Cancers
8.11. Prostate Cancers
8.12. Skin Cancers
9. Americas Cancer Biopsy Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cancer Biopsy Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cancer Biopsy Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Agena Bioscience, Inc.
13.1.2. Agilent Technologies Inc.
13.1.3. ANGLE PLC
13.1.4. Becton, Dickinson and Company
13.1.5. BIOCEPT, Inc.
13.1.6. Danaher Corporation
13.1.7. Epigenomics AG
13.1.8. Exact Sciences Corporation
13.1.9. F. Hoffmann-La Roche Ltd.
13.1.10. Freenome Holdings, Inc.
13.1.11. GRAIL, Inc.
13.1.12. Guardant Health
13.1.13. HelioHealth
13.1.14. Hologic, Inc.
13.1.15. Illumina, Inc.
13.1.16. Laboratory Corporation of America Holdings
13.1.17. Lucence Health Inc.
13.1.18. MDx Health
13.1.19. Myriad Genetics, Inc.
13.1.20. Natera, Inc.
13.1.21. OncoCyte Corp
13.1.22. Personalis Inc.
13.1.23. QIAGEN N.V.
13.1.24. Thermo Fisher Scientific, Inc.
13.1.25. Trovagene, Inc
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. CANCER BIOPSY MARKET RESEARCH PROCESS
FIGURE 2. CANCER BIOPSY MARKET SIZE, 2023 VS 2030
FIGURE 3. CANCER BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CANCER BIOPSY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CANCER BIOPSY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CANCER BIOPSY MARKET DYNAMICS
FIGURE 7. CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CANCER BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. CANCER BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CANCER BIOPSY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. CANCER BIOPSY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CANCER BIOPSY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CANCER BIOPSY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CANCER BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. CANCER BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CANCER BIOPSY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CANCER BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CANCER BIOPSY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. CANCER BIOPSY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CANCER BIOPSY MARKET SIZE, BY KITS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CANCER BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 10. CANCER BIOPSY MARKET SIZE, BY LIQUID BIOPSIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 13. CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 15. CANCER BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CANCER BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CANCER BIOPSY MARKET SIZE, BY SURGICAL BIOPSIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 19. CANCER BIOPSY MARKET SIZE, BY BLOOD CANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CANCER BIOPSY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CANCER BIOPSY MARKET SIZE, BY CERVICAL CANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CANCER BIOPSY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. CANCER BIOPSY MARKET SIZE, BY KIDNEY CANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. CANCER BIOPSY MARKET SIZE, BY LIVER CANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. CANCER BIOPSY MARKET SIZE, BY LUNG CANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. CANCER BIOPSY MARKET SIZE, BY OVARIAN CANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. CANCER BIOPSY MARKET SIZE, BY PANCREATIC CANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. CANCER BIOPSY MARKET SIZE, BY PROSTATE CANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. CANCER BIOPSY MARKET SIZE, BY SKIN CANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. CANADA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. CANADA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 49. CANADA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 50. CANADA CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 54. MEXICO CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 55. MEXICO CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CANCER BIOPSY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. CHINA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. CHINA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. CHINA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 76. CHINA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 77. CHINA CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. INDIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. INDIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 81. INDIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 82. INDIA CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. JAPAN CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. JAPAN CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. JAPAN CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 91. JAPAN CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 92. JAPAN CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. THAILAND CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. THAILAND CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. THAILAND CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 121. THAILAND CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 122. THAILAND CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. DENMARK CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. DENMARK CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. DENMARK CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 137. DENMARK CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 138. DENMARK CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. EGYPT CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. EGYPT CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. EGYPT CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 142. EGYPT CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 143. EGYPT CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. FINLAND CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. FINLAND CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. FINLAND CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 147. FINLAND CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 148. FINLAND CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. FRANCE CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. FRANCE CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 152. FRANCE CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 153. FRANCE CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. GERMANY CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. GERMANY CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 157. GERMANY CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 158. GERMANY CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. ITALY CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. ITALY CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 167. ITALY CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 168. ITALY CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. NORWAY CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. NORWAY CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. NORWAY CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 182. NORWAY CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 183. NORWAY CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. POLAND CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. POLAND CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. POLAND CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 187. POLAND CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 188. POLAND CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. QATAR CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. QATAR CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. QATAR CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 192. QATAR CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 193. QATAR CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 209. SPAIN CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. SPAIN CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SPAIN CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 212. SPAIN CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 213. SPAIN CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. TURKEY CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. TURKEY CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 227. TURKEY CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM CANCER BIOPSY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 239. CANCER BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 240. CANCER BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 241. CANCER BIOPSY MARKET LICENSE & PRICING

Companies Mentioned

  • Agena Bioscience, Inc.
  • Agilent Technologies Inc.
  • ANGLE PLC
  • Becton, Dickinson and Company
  • BIOCEPT, Inc.
  • Danaher Corporation
  • Epigenomics AG
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • Freenome Holdings, Inc.
  • GRAIL, Inc.
  • Guardant Health
  • HelioHealth
  • Hologic, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Lucence Health Inc.
  • MDx Health
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • OncoCyte Corp
  • Personalis Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
  • Trovagene, Inc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 33.48 Billion
Forecasted Market Value ( USD ) by 2030 $ 67.14 Billion
Compound Annual Growth Rate12.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Cancer Biopsy Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Core Needle Biopsy), By Application (Breast Cancer, Lung Cancer), By Product (Kits & Consumables, Instruments), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Cancer Biopsy Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Core Needle Biopsy), By Application (Breast Cancer, Lung Cancer), By Product (Kits & Consumables, Instruments), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 140 Pages
  • Global
From
Global Breast Cancer Core Needle Biopsy Market Size, Share & Trends Analysis Report by Technology, End-use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes), Region, and Segment Forecasts, 2023-2030 - Product Image

Global Breast Cancer Core Needle Biopsy Market Size, Share & Trends Analysis Report by Technology, End-use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes), Region, and Segment Forecasts, 2023-2030

  • Report
  • 120 Pages
  • Global
From
Global Breast Biopsy Market by Product (Assay Kits, Biopsy Needles, Biopsy Tables), Type (Liquid Breast Biopsy, Needle Breast Biopsy, Open Surgical Breast Biopsy), Guidance, Application - Forecast 2024-2030 - Product Image

Global Breast Biopsy Market by Product (Assay Kits, Biopsy Needles, Biopsy Tables), Type (Liquid Breast Biopsy, Needle Breast Biopsy, Open Surgical Breast Biopsy), Guidance, Application - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Breast Biopsy Devices Market by Type (Needles, Tables, Assay Kits, Liquid Biopsy), Procedure (CNB, FNAB, VAB, Surgical), Technique (Stereotactic, USG, MRI), Application (Screening, Treatment), End User (Hospitals, Clinic) & Region - Global Forecast to 2028 - Product Image

Breast Biopsy Devices Market by Type (Needles, Tables, Assay Kits, Liquid Biopsy), Procedure (CNB, FNAB, VAB, Surgical), Technique (Stereotactic, USG, MRI), Application (Screening, Treatment), End User (Hospitals, Clinic) & Region - Global Forecast to 2028

  • Report
  • 260 Pages
  • Global
From
Global Smart Biopsy Devices Market by Application (Breast cancer, Liver cancer, Prostate cancer), End-User (Academic & Research Institutes, Diagnostic & Imaging Centers, Hospitals) - Forecast 2024-2030 - Product Image

Global Smart Biopsy Devices Market by Application (Breast cancer, Liver cancer, Prostate cancer), End-User (Academic & Research Institutes, Diagnostic & Imaging Centers, Hospitals) - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From

About the Market

The Cancer Biopsy market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. It is used to detect and diagnose cancer in patients, and is a key component of the IVD industry. Cancer biopsy tests are used to detect the presence of cancer cells in a sample of tissue taken from the patient. The sample is then analyzed to determine the type and stage of cancer. The results of the biopsy can help guide treatment decisions. The Cancer Biopsy market is driven by the increasing prevalence of cancer, advances in technology, and the growing demand for early diagnosis and treatment. The market is expected to continue to grow in the coming years, as more advanced tests become available and the demand for early diagnosis and treatment increases. Some of the major companies in the Cancer Biopsy market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.